Clinical Trials Directory

Trials / Completed

CompletedNCT01884649

Fetuin A in Hashimoto Thyroiditis

Fetuin A as a New Marker of Inflammation in Hashimoto Thyroiditis

Status
Completed
Phase
Study type
Observational
Enrollment
97 (actual)
Sponsor
Istanbul Medeniyet University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Fetuin-A levels are reported to be low as a negative acute phase reactant in systemical inflammatory situations. Hashimoto thyroiditis is characterized with inflammation. In this study, we hypothesised that the serum fetuin A levels could be found to be low due to inflammation in patients with Hashimoto thyroiditis

Detailed description

Patients ≥ 20 years of age being followed up at the outpatient clinics of the Internal Medicine Department in Medeniyet University Goztepe Training and Research Hospital and fulfilling the eligibility criteria will be included in the study. Approval of the local ethics committee and informed consent of the participants will be received for the study. The study is conducted in accordance with the Declaration of Helsinki. Demographic characteristics, concomitant diseases, smoking and alcohol drinking habits, concomitant medication usage, anthropometric and biochemistry data of the eligible patients will be recorded. Patient group will consist of patients with newly diagnosed Hashimoto thyroiditis and the control group will consist of healthy volunteers. Groups will be compared according to their demographic, an¬thropometric and biochemistry data and serum fetuin-A levels. In order to detect the relationship between the serum fetuin-A levels and clinical features, correlation analyses will be done.

Conditions

Timeline

Start date
2012-05-01
Primary completion
2012-10-01
Completion
2012-10-01
First posted
2013-06-24
Last updated
2013-06-24

Source: ClinicalTrials.gov record NCT01884649. Inclusion in this directory is not an endorsement.